Core Viewpoint - Shanghai Shangmei Cosmetics Co., Ltd. (02145.HK) has released a positive profit forecast for the first half of 2025, indicating strong revenue and net profit growth driven by its main brand Han Shu and the second growth curve brand New Page [1][2] Group 1: Financial Performance - For the first half of 2025, the company expects revenue to be between RMB 4.09 billion and RMB 4.11 billion, representing a year-on-year growth of 16.8% to 17.3% [1] - The net profit is projected to reach between RMB 540 million and RMB 560 million, showing a significant year-on-year increase of 30.9% to 35.8% [1] Group 2: Brand Strategy - The company is advancing a "single focus, multi-brand, globalization" strategy, creating a multi-brand matrix that includes the main brand Han Shu and the second curve brand New Page, achieving comprehensive layout across multiple categories and price ranges [2][10] - Han Shu has achieved a breakthrough in all-channel growth, with GMV on Douyin exceeding RMB 3.63 billion in the first half of 2025, maintaining its position as the top-selling beauty brand on the platform [4] Group 3: Product Innovation - The Han Shu brand has successfully launched innovative products, such as the Hong Man Yao series, which sold over 14 million sets, and the Bai Man Yao series targeting the whitening market, reinforcing the brand's market recognition for "functional skincare" [4] - New Page has shown strong growth since its launch in 2022, with a strategic upgrade focusing on "effective skincare" for all age groups, achieving a sales increase of 106% during the 618 shopping festival [6] Group 4: Competitive Advantage - The Anminyou brand targets the sensitive skin segment with its core ingredient "Artemisia Oil AN+", providing a gentle solution for sensitive skin, enhancing the company's professional skincare portfolio [8] - The company has established a complete innovation matrix in the hair care sector, launching differentiated brands like Jifang and Han Shu Hair Care, focusing on functional hair care and scalp anti-aging [8] Group 5: Research and Development - The company emphasizes R&D as a strategic priority, having established a 3.0 innovation R&D system and an "1+N open innovation platform" to integrate global scientific resources [11] - In 2024, Han Shu achieved a significant technological breakthrough with the approval of its self-developed cyclic peptide-9 anti-aging ingredient by the National Medical Products Administration [13] Group 6: Manufacturing and Future Goals - The company has built an international and intelligent production system, with a smart factory that operates fully automated processes from raw material scheduling to finished product delivery [14] - The company aims to reach a strategic target of RMB 30 billion by 2030, leveraging clear strategic planning and continuous R&D investment to transition from following international brands to leading industry development [16]

Performance Summary - Techtronic Industries (00669.HK) reported a revenue of $7.8 billion for the first half of the year, an increase of 7.5% year-on-year, with a net profit of $628 million, up 14.2% [1] - Yum China (09987.HK) achieved revenue of $2.8 billion in Q2 2025, a 4% increase year-on-year, with an operating profit of $304 million, up 14% [1] - Shiseido (02145.HK) expects mid-term revenue of approximately ¥4.09-4.11 billion, a year-on-year increase of about 16.8%-17.3%, and a net profit of approximately ¥540-560 million, up about 30.9%-35.8% [1] - Prosperity Industrial Trust (00778.HK) reported revenue of approximately HK$854 million for the first half, a decrease of about 2% year-on-year, while distributable income to unitholders increased by 2.06% to HK$377 million [1] - Zibuyu (02420.HK) anticipates mid-term revenue of approximately RMB 1.9-2.047 billion, a year-on-year increase of about 30%-40%, with a net profit of approximately RMB 100-110 million, up about 10%-20% [1] - Angelalign Technology (06699.HK) expects mid-term net profit of approximately $13.4-14.8 million, a year-on-year increase of approximately 538.1%-604.8% [1] Company News - Sunac China (01918.HK) reported a cumulative contract sales amount of ¥25.08 billion for the first seven months of 2025, a decrease of 9.43% year-on-year, with July contract sales of approximately ¥1.53 billion, an increase of 8.51% [3] - Xingye Holdings (00132.HK) entered into a financing lease agreement with Heilongjiang Mudanjiang Agricultural Reclamation Xinneng Thermal Power, involving an investment of ¥100 million [3] - China Biopharmaceutical (01177.HK) received NMPA approval for the clinical trial application of TQC3302, an ICS/LAMA/LABA soft mist inhalation formulation for the maintenance treatment of chronic obstructive pulmonary disease [3] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.05 million shares at a cost of about HK$105 million, with buyback prices ranging from HK$95.35 to HK$96.3 [3] - Hang Seng Bank (00011.HK) repurchased 200,000 shares at a cost of approximately HK$22.717 million, with buyback prices between HK$113.1 and HK$114.2 [4]

Core Viewpoint - The company expects significant revenue and profit growth for the six months ending June 30, 2025, driven by its skincare brands and product diversification [1] Revenue Summary - The projected revenue for the six months ending June 30, 2025, is estimated to be between approximately RMB 40.90 billion and RMB 41.10 billion, representing an increase of about 16.8% to 17.3% compared to the revenue of approximately RMB 35.024 billion for the six months ending June 30, 2024 [1] Profit Summary - The anticipated profit for the same period is expected to be between approximately RMB 5.40 billion and RMB 5.60 billion, which indicates an increase of about 30.9% to 35.8% compared to the profit of approximately RMB 4.124 billion for the six months ending June 30, 2024 [1] Growth Drivers - The revenue and profit increase is primarily attributed to the continuous growth from the scientific anti-aging skincare brand Han Shu and the significant year-on-year revenue increase from the Chinese infant skincare brand Newpage [1]

根据目前可得资料，收入及利润增加主要由于集团科学抗衰护肤品牌韩束全渠道多品类的布局带来的收 入持续增长及中国婴童功效护肤品牌newpage一页的收入同比大幅增长。 格隆汇8月5日丨上美股份(02145.HK)公告，集团截至2025年6月30日止6个月未经审核综合管理账目的初 步审阅及对董事会目前可获得资料的评估，集团预计(i)截至2025年6月30日止6个月的收入约人民币40.9 亿元至人民币41.1亿元，同比增加约16.8%至17.3%；及(ii)截至2025年6月30日止6个月的公司利润约人 民币5.4亿元至人民币5.6亿元，同比增加约30.9%至35.8%。 ...

智通财经APP讯，上美股份(02145)发布公告，集团预计截至2025年6月30日止六个月的收入介于约人民 币40.90亿元至41.10亿元，较截至2024年6月30日止六个月的收入约人民币35.024亿元增加约16.8%至 17.3%;及截至2025年6月30日止六个月的公司利润介于约人民币5.40亿元至5.60亿元，较截至2024年6月 30日止六个月的公司利润约人民币4.124亿元增加约30.9%至35.8%。 收入及利润增加主要由于集团科学抗衰护肤品牌韩束全渠道多品类的布局带来的收入持续增长及中国婴 童功效护肤品牌newpage一页的收入同比大幅增长。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 Shanghai Chicmax Cosmetic Co., Ltd. 上海上美化妝品股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2145） 正面盈利預告 本公告乃由上海上美化妝品股份有限公司（「本公司」，連同其附屬公司統稱「本集 團」）根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09(2)(a)條及 證券及期貨條例（香港法例第571章）第XIVA部項下的內幕消息條文（定義見上市 規則）作出。 本公司董事會（「董事會」）謹此知會本公司股東（「股東」）及有意投資者，基於對 本集團截至2025年6月30日止六個月未經審核綜合管理賬目的初步審閱及對董事 會目前可獲得資料的評估，本集團預計(i)截至2025年6月30日止六個月的收入介 乎約人民幣4,090.0百萬元至人民幣4,110.0百萬元，較截至2024年6月30日止六 個月的收入約人民幣3,502.4百萬元增加約 ...

Summary of Shangmei Co., Ltd. Conference Call Company Overview - Shangmei Co., Ltd. reported a revenue of 6.7 billion RMB in 2024, representing a year-on-year growth of 62.1%, with net profit increasing by 74% [2][3] - The company was founded in 2002 and focuses on skincare, hair care, and maternal and infant products, with brands including Han Shu, New Page, Yi Ye Zi, Red Elephant, and Anminyou [3] Core Strategies and Insights - **Brand Premiumization Strategy**: Shangmei adopts a dual-track strategy for brand premiumization, enhancing product efficacy through self-developed core ingredients (e.g., Anminyou's artemisinin oil) and IP collaborations (e.g., with the "Anpanman" brand for maternal and infant care) [2][4] - **Channel Strategy Adjustment**: The company is shifting from a heavy focus on Douyin to a multi-channel approach, with Douyin's channel share slightly decreasing to 75% in Q1 2025, while Tmall and JD.com are gaining share [2][6] - **"2+2+2" Brand Strategy**: This strategy targets mass, mid-to-high-end, and high-end markets across skincare, maternal and infant care, and hair care categories [2][7] Product Performance - **Han Shu Brand**: Han Shu's red waist series 2.0 version has sold over 14 million sets, and new high-margin products like Chatai Super Frequency Cream are expected to enhance profitability [2][8] - **Growth Projections**: The Han Shu brand is expected to achieve approximately 20% growth in 2025, driven by anti-aging, men's skincare, and color cosmetics segments [2][9] Future Growth Drivers - **Emerging Brands**: New Page is rapidly growing in the maternal and infant care market, with plans to expand into teenage care and color cosmetics [2][9] - **New Product Launches**: The upcoming brands, such as Nambeauty and the Anpanman collaboration, are projected to achieve over 100 million RMB in sales in their first year [2][9] Profitability Enhancement Measures - **High-Margin Product Focus**: Increasing the proportion of high-margin new products, such as Han Shu's new offerings, is expected to boost overall gross and net profit margins [2][10] - **Channel Optimization**: A strategic reduction in the proportion of live streaming sales and an increase in self-broadcasting and high-margin channels like Tmall and JD.com will enhance profitability [2][10] - **Sales Expense Reduction**: The company anticipates a gradual decrease in sales expense ratio, projected to drop by about 1 percentage point annually from 2025 to 2027 [2][10] Financial Outlook - Shangmei is expected to achieve revenue growth rates of 24.1%, 20.8%, and 20.7% from 2025 to 2027, with adjusted net profits growing by 33.8%, 21.4%, and 18.8% respectively [2][10]

Core Viewpoint - The stock of Shangmei Co., Ltd. (02145) has seen a significant increase, with a rise of over 10% during trading, reflecting strong performance in the domestic beauty brand sector and particularly in the Douyin channel [1] Group 1: Company Performance - Shangmei Co., Ltd. reported a stock price increase of 9.12%, reaching HKD 82.55, with a trading volume of HKD 152 million [1] - The company’s brand, Han Shu, achieved a GMV of HKD 6.749 billion in 2024, representing a year-on-year growth of 102%, ranking first in the Douyin beauty category [1] - The online self-operated channel revenue share is expected to rise from 39.6% in 2022 to 78.2% in 2024, driven by the rapid growth in the Douyin channel [1] Group 2: Market Trends - Domestic beauty brands are experiencing substantial growth, with notable increases such as Han Shu at 58%, Proya at 23%, Marubi at 72%, and Kefu Mei at 28% in July [1] - The multi-channel strategy, including significant growth in Tmall and JD during the Double Eleven shopping festival, is expected to enhance market share and reduce reliance on a single channel [1]

Core Viewpoint - The stock of Shumei Co., Ltd. (02145) has seen a significant increase, with a rise of over 10% during trading, reflecting strong performance in the domestic beauty brand market and particularly in the Douyin channel [1] Group 1: Company Performance - Shumei Co., Ltd. reported a stock price of 82.55 HKD, with a trading volume of 1.52 billion HKD [1] - The company has achieved notable growth in its brands, with Han Shu growing by 58%, Proya by 23%, Marubi by 72%, and Kefu Mei by 28% in July [1] - Han Shu is leading the Douyin beauty and skincare segment, indicating strong brand positioning [1] Group 2: Market Trends - According to Open Source Securities, domestic brands are gradually releasing their product advantages, with the potential to further expand market share [1] - Industrial growth is supported by the rapid increase in online self-operated channel revenue, which is projected to rise from 39.6% in 2022 to 78.2% in 2024 [1] Group 3: Sales Projections - For 2024, Han Shu's Gross Merchandise Volume (GMV) is expected to reach 6.749 billion, representing a year-on-year growth of 102% [1] - The company is also experiencing significant growth in other e-commerce channels, with projected GMV growth rates of 57% and 115% for Tmall and JD.com during the Double Eleven shopping festival in 2024, respectively [1] - The multi-channel strategy is aiding the company in expanding its market share and reducing reliance on a single sales channel [1]

Core Viewpoint - The stock of Shangmei Co., Ltd. (02145) has seen a significant increase, with a rise of over 10% during trading, attributed to strong growth in domestic beauty brands and successful performance on platforms like Douyin [1] Group 1: Company Performance - Shangmei Co., Ltd. reported a stock price increase of 9.12%, reaching HKD 82.55, with a trading volume of HKD 152 million [1] - The brand Han Shu achieved a remarkable growth of 58% in July, while other brands like Proya and Marubi also showed substantial growth rates of 23% and 72% respectively [1] - The company's GMV (Gross Merchandise Volume) for Han Shu is projected to reach 6.749 billion in 2024, representing a year-on-year growth of 102%, making it the top-ranked beauty brand on Douyin [1] Group 2: Market Trends - The domestic beauty brand market is experiencing a significant upward trend, with platforms like Douyin contributing to the growth of these brands [1] - The online self-operated channel revenue share for Shangmei Co., Ltd. is expected to rise from 39.6% in 2022 to 78.2% in 2024, indicating a shift towards online sales [1] - The company is also diversifying its e-commerce channels, with projected GMV growth rates for Han Shu during the Double Eleven shopping festival in 2024 of 57% on Tmall and 115% on JD.com [1]